Neuralstem, Inc. (CUR):企業のM&A・提携動向(医療機器分野)

◆英語タイトル:Neuralstem, Inc. (CUR) - Medical Equipment - Deals and Alliances Profile
◆商品コード:GDME58466D
◆発行会社(リサーチ会社):GlobalData
◆発行日:2016年2月25日
◆ページ数:34
◆レポート形式:英語 / PDF
◆納品方法:Eメール
◆調査対象地域:アメリカ
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥27,750見積依頼/購入/質問フォーム
Site License(同一国内共有可)USD500 ⇒換算¥55,500見積依頼/購入/質問フォーム
Enterprisewide License(複数国内共有可)USD750 ⇒換算¥83,250見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規代理店です。同社発行の市場リサーチレポート及びリサーチサービスに関するお問い合わせは弊社までお願い致します。GlobalData社の概要及び新刊レポートはこちらでご確認いただけます。

【レポートの概要】

Summary

Neuralstem, Inc. (Neuralstem) is a pharmaceutical company that develops and markets medicines based on human neural stem cell technology and cell therapy. The company provides cell therapy treatment for ALS, ischemic stroke, spinal cord injury, glioblastoma, multiple sclerosis, optic neuritis, alzheimer’s disease, traumatic brain injury, peripheral nerve injury, diabetic neuropathy, lysosomal disease, parkinson’s disease, huntington’s disease and cerebral palsy. Neuralstem provides drug treatment for depressive disorder, cognitive complication due to diabetes, post traumatic stress disorder, neurodegeneration and anti aging. The company develops methods to generate replacement cells from neural stem cells. Neuralstem is headquartered in Germantown, Maryland, the US

Neuralstem, Inc. (CUR) – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 2
List of Tables 3
List of Figures 4
Neuralstem, Inc., Medical Equipment, Deals By Year, 2010 to YTD 2016 5
Neuralstem, Inc., Medical Equipment Deals By Type, 2010 to YTD 2016 6
Neuralstem, Inc., Medical Equipment, Deals By Region, 2010 to YTD 2016 7
Neuralstem, Inc., Medical Equipment, Deals By Market, 2010 to YTD 2016 8
Neuralstem, Inc., Medical Equipment, Deals Summary, 2010 to YTD 2016 9
Neuralstem, Inc., Medical Equipment, Deal Details 10
Partnerships 10
Neuralstem Enters Into Licensing Agreement With Cedars-Sinai Medical Center 10
Neuralstem Enters Into Licensing Agreement With Q Therapeutics For Surgical Device Platform 11
Equity Offering 12
Neuralstem to Raise up to USD20 Million in Public Offering of Shares 12
Neuralstem Completes Public Offering Of Common Stock For US$2.8 Million 14
Neuralstem Completes Private Placement Of Common Stock For US$5.2 Million 15
Neuralstem Completes Registered Direct Offering Of Units For US$10 Million 17
Neuralstem Receives Equity Investment Of US$1.5 Million 19
Neuralstem, Inc. – Key Competitors 20
Key Employees 21
Locations And Subsidiaries 22
Head Office 22
Recent Developments 23
Financial Announcements 23
Nov 09, 2015: Neuralstem Reports Third Quarter 2015 Financial Results 23
Aug 10, 2015: Neuralstem Reports Second Quarter 2015 Financial Results 25
May 08, 2015: Neuralstem Reports First Quarter 2015 Financial Results And Provides Business and Clinical Update 27
Mar 16, 2015: Neuralstem Reports Fiscal 2014 Fourth Quarter Financial And Year-End Business Results 29
Corporate Communications 31
Feb 16, 2016: Neuralstem Appoints Richard Daly as President and Chief Executive Officer 31
May 06, 2015: Neuralstem Appoints Jonathan Lloyd Jones as Chief Financial Officer 32
Legal and Regulatory 33
Jul 23, 2015: US District Court Rules In Favor Of Neuralstem In Patent Infringement Case 33
Appendix 34
Methodology 34
About GlobalData 34
Contact Us 34
Disclaimer 34

List of Tables
Neuralstem, Inc., Medical Equipment, Key Facts, 2014 1
Neuralstem, Inc., Medical Equipment, Deals Summary, 2010 to YTD 2016 1
Neuralstem, Inc., Medical Equipment, Deals By Year, 2010 to YTD 2016 5
Neuralstem, Inc., Medical Equipment Deals By Type, 2010 to YTD 2016 6
Neuralstem, Inc., Medical Equipment, Deals By Region, 2010 to YTD 2016 7
Neuralstem, Inc., Deals By Market, 2010 to YTD 2016 8
Neuralstem, Inc., Medical Equipment, Deals Summary, 2010 to YTD 2016 9
Neuralstem Enters Into Licensing Agreement With Cedars-Sinai Medical Center 10
Neuralstem Enters Into Licensing Agreement With Q Therapeutics For Surgical Device Platform 11
Neuralstem to Raise up to USD20 Million in Public Offering of Shares 12
Neuralstem Completes Public Offering Of Common Stock For US$2.8 Million 14
Neuralstem Completes Private Placement Of Common Stock For US$5.2 Million 15
Neuralstem Completes Registered Direct Offering Of Units For US$10 Million 17
Neuralstem Receives Equity Investment Of US$1.5 Million 19
Neuralstem, Inc., Key Competitors 20
Neuralstem, Inc., Key Employees 21

List of Figures
Neuralstem, Inc., Medical Equipment, Deals by Type, 2010 to YTD 2016 1
Neuralstem, Inc., Medical Equipment, Deals By Year, 2010 to YTD 2016 1
Neuralstem, Inc., Medical Equipment, Deals By Region, 2010 to YTD 2016 1
Neuralstem, Inc., Medical Equipment, Deals By Market, 2010 to YTD 2016 1
Neuralstem, Inc., Medical Equipment, Deals By Year, 2010 to YTD 2016 5
Neuralstem, Inc., Medical Equipment, Deals by Type, 2010 to YTD 2016 6
Neuralstem, Inc., Medical Equipment, Deals By Region, 2010 to YTD 2016 7
Neuralstem, Inc., Medical Equipment, Deals by Market, 2010 to YTD 2016 8

【免責事項】
http://www.globalresearch.jp/disclaimer

★リサーチレポート[ Neuralstem, Inc. (CUR):企業のM&A・提携動向(医療機器分野)(Neuralstem, Inc. (CUR) - Medical Equipment - Deals and Alliances Profile)]についてメールでお問い合わせはこちらでお願いします。

◆H&Iグローバルリサーチのお客様(例)◆